HURA (TuHURA Biosciences) Machinery, Furniture, Equipment : $1.71 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is TuHURA Biosciences Machinery, Furniture, Equipment?

TuHURA Biosciences's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was $1.71 Mil.

TuHURA Biosciences's quarterly Machinery, Furniture, Equipment increased from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($1.67 Mil) and increased from Dec. 2024 ($1.67 Mil) to Mar. 2025 ($1.71 Mil).

TuHURA Biosciences's annual Machinery, Furniture, Equipment increased from Dec. 2022 ($1.53 Mil) to Dec. 2023 ($1.61 Mil) and increased from Dec. 2023 ($1.61 Mil) to Dec. 2024 ($1.67 Mil).

TuHURA Biosciences Machinery, Furniture, Equipment Historical Data

The historical data trend for TuHURA Biosciences's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Machinery, Furniture, Equipment Chart

TuHURA Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

1.49

1.53

1.61

1.67

TuHURA Biosciences Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Machinery, Furniture, Equipment	Get a 7-Day Free Trial					1.61	1.65	-	1.67	1.71

TuHURA Biosciences Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

TuHURA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

PL3:Germany

Address

10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612

Website

https://www.tuhurabio.com

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.